Abstract
IntroductionEosinophilic granulomatosis with polyangiitis (EGPA) is a multi-system disorder characterised by asthma, eosinophilia, and vasculitis. Treatment options include oral corticosteroids (OCS) and other immunosuppressants. Recently, the anti-IL5 biologic mepolizumab has...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
